Dexcom logo

Dexcom Share Price Today

(NASDAQ: DXCM)

Dexcom share price is $84.7 & ₹7,240.33 as on 9 May 2025, 09.30 hrs IST

$84.7

-0.64

(-0.75%)

Market is closed - opens 7 PM, 12 May 2025

View live Dexcom share price in Dollar and Rupees. Guide to invest in Dexcom stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Dexcom, along with analyst recommendations, forecasts, and comprehensive financials.

Dexcom share price movements

  • Today's Low: $84.64
    Today's High: $85.56

    Day's Volatility :1.08%

  • 52 Weeks Low: $57.52
    52 Weeks High: $132.26

    52 Weeks Volatility :56.51%

Dexcom (DXCM) Returns

PeriodDexcom, Inc.Sector (Health Care)Index (Russel 2000)
3 Months
-4.04%
-9.1%
0.0%
6 Months
20.47%
-11.1%
0.0%
1 Year
-32.21%
-7.6%
0.0%
3 Years
8.76%
5.3%
3.0%

Dexcom (DXCM) Key Statistics

in dollars & INR

Previous Close
$85.34
Open
$84.87
Today's High
$85.56
Today's Low
$84.64
Market Capitalization
$33.2B
Today's Volume
$3.3M
52 Week High
$132.26
52 Week Low
$57.52
Revenue TTM
$4.1B
EBITDA
$857.8M
Earnings Per Share (EPS)
$1.33
PE Ratio
63.66
Profit Margin
12.9%
Quarterly Earnings Growth YOY
-0.26%
Return On Equity TTM
23.72%

How to invest in Dexcom Stock (DXCM) from India?

It is very easy for Indian residents to invest directly in Dexcom from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Dexcom stock in both Indian Rupees (INR) and US Dollars (USD). Search for Dexcom or DXCM on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Dexcom or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Dexcom shares which would translate to 0.010 fractional shares of Dexcom as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Dexcom, in just a few clicks!

Returns in Dexcom (DXCM) for Indian investors in Rupees

The Dexcom stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Dexcom investment value today

Current value as on today

₹70,169

Returns

₹29,831

(-29.83%)

Returns from Dexcom Stock

₹32,213 (-32.21%)

Dollar Returns

₹2,382 (+2.38%)

Indian investors sentiment towards Dexcom (DXCM)

-23.61%

Period: Apr 10, 2025 to May 10, 2025. Change in 30 Days versus previous period

Investment in Dexcom Shares from India has dropped by -23.61% over the past 30 days, indicating reduced transactional activity.

352%

Period: Apr 10, 2025 to May 10, 2025. Change in 30 Days versus previous period

Search interest for Dexcom Stock from India on INDmoney has increased by 352% in the last 30 days, reflecting an upward trend in search activity.

Indian Mutual Funds that invest in Dexcom Stock (DXCM Ticker)

NameShares HeldChange in Shares% of Assets
Motilal Oswal S&P 500 Index Fund Direct Growth logo
3254
-39.44
0.06%
ICICI Prudential NASDAQ 100 Index Fund Direct Growth logo
5012
-179.03
0.18%

Global Institutional Holdings in Dexcom

  • Vanguard Group Inc

    11.87%

  • BlackRock Inc

    10.10%

  • State Street Corp

    4.26%

  • Baillie Gifford & Co Limited.

    3.73%

  • Capital Research Global Investors

    3.67%

  • Sands Capital Management, LLC

    2.83%

Analyst Recommendation on Dexcom

Rating
Trend

Buy

    86%Buy

    13%Hold

    0%Sell

Based on 30 Wall street analysts offering stock ratings for Dexcom(by analysts ranked 0 to 5 stars)

Analyst Forecast on Dexcom Stock (DXCM)

What analysts predicted

Upside of 15.33%

Target:

$97.68

Current:

$84.70

Insights on Dexcom Stock (Ticker Symbol: DXCM)

  • Price Movement

    In the last 1 month, DXCM stock has moved up by 28.1%
  • Decreasing Revenue

    Dexcom, Inc. has seen a decline in its revenue over the last two quarters. The revenue dropped from $1.11 billion to $1.03 billion, reflecting an average decrease of 7.0% per quarter.
  • Decreasing Net Profit

    Dexcom, Inc. has seen a decline in its net profit over the last two quarters. The company's net profit decreased from $151.7 million to $105.4 million, averaging a decrease of 30.5% per quarter.
  • DXCM vs BSX (1 yr)

    In the last 1 year, Boston Scientific Corp. has given 39.6% return, outperforming this stock by 72.9%
  • DXCM vs BSX (3 yr)

    In the last 3 years, Boston Scientific Corp. has given 165.6% return, outperforming this stock by 158.0%
  • Price to Sales

    Dexcom, Inc. has a Price-to-Sales Ratio of 8.0, meaning investors are willing to pay $8.0 for every $1 of sales the company generates. In comparison, Boston Scientific Corp. has a slightly higher Price-to-Sales Ratio of 8.6, indicating that investors are paying more for each dollar of sales for Boston Scientific compared to Dexcom.

Dexcom Technicals Summary

Sell

Neutral

Buy

Dexcom is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Dexcom (DXCM) Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Dexcom, Inc. logo
28.06%
20.47%
-32.21%
8.76%
-17.53%
Medtronic Plc logo
0.71%
-5.42%
-0.04%
-17.43%
-12.3%
Edwards Lifesciences Corp. logo
6.18%
10.48%
-13.0%
-21.14%
1.66%
Boston Scientific Corp. logo
9.84%
16.29%
41.31%
165.25%
178.23%
Stryker Corporation logo
8.8%
0.59%
17.42%
67.15%
102.53%
Abbott Laboratories logo
5.04%
14.1%
27.2%
23.43%
42.08%

About Dexcom

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for the management of diabetes and metabolic health by patients, caregivers, and clinicians. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions; and Stelo, a new over-the-counter glucose biosensor designed for adults with prediabetes and Type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.
Organization
Dexcom
Employees
10200
CEO
Mr. Kevin Ronald Sayer
Industry
Health Technology

Management People of Dexcom

NameTitle
Mr. Kevin Ronald Sayer
Executive Chairman, CEO & President
Mr. Jereme M. Sylvain CPA
Executive VP, CFO & Chief Accounting Officer
Mr. Jacob Steven Leach
Executive VP & COO
Mr. Michael Jon Brown
Executive VP & Chief Legal Officer
Ms. Sadie M. Stern
Executive VP & Chief Human Resources Officer
Mr. Girish Naganathan
Executive VP & CTO
Mr. Sean Christensen
Vice President of Finance and Investor Relations
Mr. Matthew Dolan
Executive Vice President of Strategy, Corporate Development & Dexcom Labs
Ms. Leverne Marsh
Executive Vice President of Marketing
Mr. Donald M. Abbey
Executive Vice President of Global Business Services, IT, Quality & Regulatory Affairs

Important FAQs about investing in DXCM Stock from India :

Can Indians buy Dexcom shares?

Yes, Indians can invest in the Dexcom (DXCM) from India.

With INDmoney, you can buy Dexcom at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Dexcom at zero transaction cost.

How can I buy Dexcom shares from India?

It is very easy to buy Dexcom from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Dexcom (DXCM) be purchased?

Yes, you can buy fractional shares of Dexcom with INDmoney app.

What are the documents required to start investing in Dexcom stocks?

To start investing in Dexcom, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What is Dexcom share price today?

Dexcom share price today stands at $84.70, Open: $84.87 ; Previous Close: $85.34 ; High: $85.56 ; Low: $84.64 ; 52 Week High: $132.26 ; 52 Week Low: $57.52.

The stock opens at $84.87, after a previous close of $85.34. The stock reached a daily high of $85.56 and a low of $84.64, with a 52-week high of $132.26 and a 52-week low of $57.52.

What are today’s High and Low prices of Dexcom Stock (DXCM)?

Today’s highest price of Dexcom (DXCM) is $85.56.

Today’s lowest price of Dexcom (DXCM) is $84.64.

What is the 52 Week High and Low Range of Dexcom Stock (DXCM)?

  • 52 Week High

    $132.26

  • 52 Week Low

    $57.52

What are the historical returns of Dexcom (DXCM)?

  • 1 Month Returns

    28.06%

  • 3 Months Returns

    20.47%

  • 1 Year Returns

    -32.21%

  • 5 Years Returns

    -17.53%

What is today's market capitalisation of Dexcom?

Today's market capitalisation of Dexcom DXCM is 33.2B

Who is the Chief Executive Officer (CEO) of Dexcom ?

Mr. Kevin Ronald Sayer is the current Chief Executive Officer (CEO) of Dexcom.

Discover More